🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ESTRO25 - Day 4 🌟 Best Papers & Donal Hollywood Award🏆 #BreastCancer ▶️ FAST-Forward nodal substudy : 5-year normal tissue effects following 1-week versus 3-week axillary radiotherapy for breast cancer (ISRCTN19906132) by @ Adrian Murray Brunt ESTRO Icro Meattini

#ESTRO25 - Day 4 🌟 Mini-Oral & #BreastCancer ▶️ Intraoperative radiotherapy in elderly patients with breast cancer: long-term follow-up results of the prospective phase Il trial TARGIT-E by Elena Sperk ESTRO

#ESTRO25 - Day 4 🌟 Mini-oral & #BreastCancer ▶️ Emulated target trial in the CANTO-RT cohort assessing tumor bed boost in post-menopausal breast cancer patients by Simon Delaunay ESTRO Gustave Roussy

#ESTRO25 - Day 4 🌟 #BreastCancer ▶️ Ultra-hypofractionated WBI in early stage breast cancer: an Italian multicentric observational study (NCT05586256) by Anna Giulia Becchetti ESTRO

#ESTRO25 - Day 4 🌟 #BreastCancer ▶️ Breaking Barriers in Breast Cancer Trials: Non-Accrual Insights from the phase Ill randomized clinical DBCG NATURAL and PROTON trials by Baisner Bjarke Godske ESTRO

#ESTRO25 - Day 5 🌟 Best practices in patient involvement: A win-win for cancer societies and patients 🤝 ▶️ Patients as partners for guiding scientific and professional societies by Tanja Spanic ESTRO OncoAlert #BreastCancer

Dear Colleagues, You are warmly invited to watch the Top Trials of the Year🚨 presented by some of the world’s leading experts. All sessions are free and available on demand NO REGISTRATION NEEDED, JUST CLICK AND WATCH ⭐ GU Oncology buff.ly/3hkYYG6 ⭐ #BreastCancer

▶️ End of #ESTRO25 🌟 A great time, full of impactful & interesting presentations and exchanges with colleagues & friends ! An honor to have been social media ambassador for #BreastCancer Programme Journey ! Thanks a lot for this amazing congress ! 👏 ESTRO

The OncoAlert🚨Newsletter Now Out Covering May 9-15, 2025 REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… ✅POTOMAC update from AZ💊 ✅RAVENS Trial in #ProstateCancer ✅APHINITY Trial in #BreastCancer ✅RAPIDO Trial in #RectalCancer ✅APOLLO Trial in #HCC

You are warmly invited to watch the Top Trials of the Year🚨 presented by some of the world’s leading experts. All sessions are free and available on demand NO REGISTRATION NEEDED, JUST CLICK AND WATCH ⭐ GU Oncology buff.ly/3hkYYG6 ⭐ #BreastCancer

Oncology HERE & NOW Webcast (GU Oncology) Upper Tract Urothelial Carcinoma Join our Urology colleagues, Dr. Melão Bárbara Melão, MD, PhD 🇧🇷 and Dr. Dr. Philippe Spiess Philippe spiess 🇺🇸 of Moffitt Cancer Center ⭐️Listen on Apple Podcasts 🍏 podcasts.apple.com/se/podcast/onc… ⭐️Direct Podcast link

The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸 ⭐ LBA1008: DESTINY-BREASTO9: TRASTUZUMAB DERUXTECAN (T-DXD) + PERTUZUMAB (P) VS TAXANE + TRASTUZUMAB

The #ASCO25 #OncoAlertTOP10 Abstracts in #LungCancer 🫁 These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸 ⭐ Abs 8506: HERTHENA-LUNG02: PATRITUMAB DERUXTECAN IN RESISTANT EGFR-MUTATED ADVANCED NON-SMALL

The #ASCO25 #OncoAlertTOP10 Abstracts in #SupportiveCare ,These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago 🇺🇸 #OncoAlertAF Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Biagio Ricciuti, MD, PhD Emre Yekedüz Hidehito HORINOUCHI Fadi Haddad, MD

Welcome to #ASCO25 ! On behalf of the🚨OncoAlert Network—hello from Chicago! 🌆 🔗 Sign up the Newsletter: oncoalert.m-pages.com/nhMpwe/oncoale… WE ARE ALL OncoAlert 🚨 For 7 years, we've brought you real-time updates from the biggest oncology congresses. This year, we’re back with: 🔹

The OncoAlert🚨 RoundUp DAY TWO #ASCO25 REGISTER HERE 👉 OncoAlert360.com OR buff.ly/p0O1gZ8 FOR A MORE COMPLETE VIEW of the TOP of DAY 2 of the congress Discussing:✅ ✅ASCENT-04/KEYNOTE #BreastCancer ✅VERITAC-2 in BreastCancer ✅INAVO120 in BreastCancer

The OncoAlert 🚨Newsletter will be out DAILY during #ASCO25 and in your inbox. REGISTER👉 buff.ly/hHqe5vt OR buff.ly/48Xpgz0 Make sure to follow our OncoAlert Faculty for up to the minute reports from the great science out of Chicago #OncoAlertAF

☢️ Breast Cancer & Regional Nodal RT after Response to Neoadj CT ⁉️ ▪️ 1641 pts cN1MO & ypN0 ▪️regional nodal RT vs no ▫️regional nodal RT ❌significantly increase invasive BC recurrence free interval HR 0,88 [0,60-1,28] p=0,51 OncoAlert #OncoAlertAF nejm.org/doi/full/10.10…

The OncoAlert🚨NEWSLETTER ⭐️THE COMPLETE #ASCO25 EDITION⭐️ REGISTER👉 OncoAlert360.com OR buff.ly/48Xpgz0 OUR PICKS FROM THE ENTIRE CONGRESS and Special VIDEO insights from our collaborators on specific trials OUT On Monday June 9, 2025 !!

🏃‍♀️🏋️‍♀️🔝‼️ 3-year structured exercice after adjuvant chemotherapy for colon cancer 🚨 ▶️ phase 3 : 889 pts [exercice group vs health-education group] ▶️ 📈disease-free survival HR 0,72 [0,55-0,94] p=0,02 OncoAlert #OncoAlertAF nejm.org/doi/full/10.10…